CorriXR Therapeutics Publishes NRF2 Knockout Preclinical Data
22 Jan 2026 //
BUSINESSWIRE
CorriXR, InhaTarget & Merxin Develop Inhaled Lung Cancer Therapy
02 Dec 2025 //
BUSINESSWIRE
CorriXR Publishes Preclinical Data on CRISPR Against Resistance
17 Nov 2025 //
BUSINESSWIRE
CorriXR Therapeutics Secure $1M Investment from State of Delaware
19 Aug 2025 //
BUSINESSWIRE
CorriXR Therapeutics Appoints Jan Case as Chief Operating Officer
08 Jan 2025 //
BUSINESSWIRE
CorriXR Therapeutics Names Eric Kmiec Chief Executive Officer
10 Dec 2024 //
BUSINESSWIRE
CorriXR Therapeutics Announces Deborah Moorad as Its New Chief Executive Officer
19 Sep 2023 //
BUSINESSWIRE

Market Place
Sourcing Support